Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging

Movement Disorders

Volumn 28, Issue 13, 2013, Pages 1886-1890

  Rizzo, Giovanni ^a,b   Manners, David ^a   Testa, Claudia ^a   Tonon, Caterina ^a   Vetrugno, Roberto ^c   Marconi, Sara ^a,b   Plazzi, Giuseppe ^a,b   Pizza, Fabio ^a,b   Provini, Federica ^a,b   Malucelli, Emil ^d   Gramegna, Laura Ludovica ^a   Lodi, Raffaele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^c Professional Consultant in Neurology   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Iron; MRI; Phase imaging; RLS

Indexed keywords

FERRITIN; IRON; NEUROMELANIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; BRAIN MAPPING; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE NUCLEUS; FEMALE; FERRITIN BLOOD LEVEL; GLOBUS PALLIDUS; GRADIENT ECHO IMAGING; HUMAN; IRON BLOOD LEVEL; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHASE TRANSITION; PRIORITY JOURNAL; PUTAMEN; RED NUCLEUS; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA; THALAMUS; TRANSFERRIN BLOOD LEVEL;

IRON; MRI; PHASE IMAGING; RLS;

AGED; BRAIN; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; STATISTICS, NONPARAMETRIC;

EID: 84887626041     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25576     Document Type: Article

References (28)

1. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol. 2005;4:465-475.
2. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101-119.
3. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22:S440-S448.
4. Nordlander NB. The therapy in restless legs. Acta Med Scand. 1953;143:453-457.
5. Earley CJ, Heckler D, Allen RP. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med. 2005;6:301-305.
6. Wang J, O'Reilly B, Venkataraman R, Mysliwiec V, Mysliwiec A. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med. 2009;10:973-975.
7. Clardy SL, Earley CJ, Allen RP, Beard JL, Connor JR. Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med. 2006;147:67-73.
8. Clardy SL, Wang X, Boyer PJ, Earley CJ, Allen RP, Connor JR. Is ferroportin-hepcidin signaling altered in restless legs syndrome? J Neurol Sci. 2006;247:173-179.
9. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61:304-309.
10. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology. 2004;62:1563-1567.
11. Earley CJ, Ponnuru P, Wang X, et al. Altered iron metabolism in lymphocytes from subjects with restless legs syndrome. Sleep. 2008;31:847-852.
12. Snyder AM, Wang X, Patton SM, et al. Mitochondrial ferritin in the substantia nigra in restless legs syndrome. J Neuropathol Exp Neurol. 2009;68:1193-1199.
13. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56:263-265.
14. Earley CJ, B Barker P, Horska A, Allen RP. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med. 2006;7:458-461.
15. Astrakas LG, Konitsiotis S, Margariti P, Tsouli S, Tzarouhi L, Argyropoulou MI. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology. 2008;71:911-916.
16. Margariti PN, Astrakas LG, Tsouli SG, Hadjigeorgiou GM, Konitsiotis S, Argyropoulou MI. Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours. AJNR Am J Neuroradiol. 2012;33:667-672.
17. Godau J, Klose U, Di Santo A, Schweitzer K, Berg D. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord. 2008;23:1184-1187.
18. Ogg RJ, Langston JW, Haacke EM, Steen RG, Taylor JS. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging. 1999;17:1141-1148.
19. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23:1-25.
20. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol. 2009;30:19-30.
21. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study group rating scale for restless legs syndrome. Sleep Med. 2003;4:121-132.
22. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol. 2005;58:630-634.
23. Dean T Jr, Allen RP, O'Donnell CP, Earley CJ. The effects of dietary iron deprivation on murine circadian sleep architecture. Sleep Med. 2006;7:634-640.
24. Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav. 2001;69:409-418.
25. Connor JR, Wang XS, Allen RP, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132:2403-2412.
26. Rizzo G, Tonon C, Testa C, et al. Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome. Brain. 2012;135:3712-3720.
27. Cervenka S, Pålhagen SE, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129:2017-2028.
28. Walters AS, Ondo WG, Zhu W, Le W. Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study. J Neurol Sci. 2009;279:62-65.